Next Article in Journal
Erratum
Previous Article in Journal
Role of Gender in Hesitancy Toward the COVID-19 Vaccine Beyond Medical Students
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
GERMS
Volume 13
Issue 4
10.18683/germs.2023.1410
germs-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles
GERMS is published by MDPI from Volume 25 Issue 4 (2025). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with the former publisher Infection Science Forum S.R.L..
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Communication

The Analysis of Saliva as Screening in Patients with COVID-like Symptoms

by
Giorgio Novelli
1,2,*,
Mattia Moretti
1,3,
Maria Costanza Meazzini
1,
Davide Paolo Bernasconi
4,
Sergio Maria Ivano Malandrin
5,
Monica Raggi
6,
Cristina Maria Angela Cassé
2,
Luca Arturo Pavesi
1 and
Davide Sozzi
1,2
1
Operative Unit of Maxillo-Facial Surgery, Fondazione IRCCS San Gerardo dei Tintori, 20900 Monza, Italy
2
Department of Medicine and Surgery, School of Medicine and Surgery, University of Milano Bicocca, 20900 Monza, Italy
3
Postgraduate School of Maxillo-Facial Surgery, University of Milan, 20122 Milan, Italy
4
Bicocca Bioinformatics Biostatistics and Bioimaging Centre-B4, School of Medicine and Surgery, University of Milano Bicocca, 20900 Monza, Italy
5
Microbiology Laboratory, Fondazione IRCCS San Gerardo dei Tintori, 20900 Monza, Italy
6
Microbiology Laboratory, ASST Monza–San Gerardo Hospital, 20900 Monza, Italy
*
Author to whom correspondence should be addressed.
GERMS 2023, 13(4), 388-391; https://doi.org/10.18683/germs.2023.1410
Submission received: 4 July 2023 / Revised: 26 December 2023 / Accepted: 30 December 2023 / Published: 31 December 2023
Versions Notes

Excerpt

Note: In lieu of an abstract, this is an excerpt from the first page.

COVID-19 (coronavirus disease-2019), caused by SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) [...]

Share and Cite

MDPI and ACS Style

Novelli, G.; Moretti, M.; Meazzini, M.C.; Bernasconi, D.P.; Malandrin, S.M.I.; Raggi, M.; Cassé, C.M.A.; Pavesi, L.A.; Sozzi, D. The Analysis of Saliva as Screening in Patients with COVID-like Symptoms. GERMS 2023, 13, 388-391. https://doi.org/10.18683/germs.2023.1410

AMA Style

Novelli G, Moretti M, Meazzini MC, Bernasconi DP, Malandrin SMI, Raggi M, Cassé CMA, Pavesi LA, Sozzi D. The Analysis of Saliva as Screening in Patients with COVID-like Symptoms. GERMS. 2023; 13(4):388-391. https://doi.org/10.18683/germs.2023.1410

Chicago/Turabian Style

Novelli, Giorgio, Mattia Moretti, Maria Costanza Meazzini, Davide Paolo Bernasconi, Sergio Maria Ivano Malandrin, Monica Raggi, Cristina Maria Angela Cassé, Luca Arturo Pavesi, and Davide Sozzi. 2023. "The Analysis of Saliva as Screening in Patients with COVID-like Symptoms" GERMS 13, no. 4: 388-391. https://doi.org/10.18683/germs.2023.1410

APA Style

Novelli, G., Moretti, M., Meazzini, M. C., Bernasconi, D. P., Malandrin, S. M. I., Raggi, M., Cassé, C. M. A., Pavesi, L. A., & Sozzi, D. (2023). The Analysis of Saliva as Screening in Patients with COVID-like Symptoms. GERMS, 13(4), 388-391. https://doi.org/10.18683/germs.2023.1410

Article Metrics

Back to TopTop